FAKTOR-OPTIONSSCHEIN - DEXCOM Stock

DE000MF67PA6

Market Closed - Börse Stuttgart 04:34:59 2024-07-12 am EDT
41.91 ^EUR	+2.59%

Current month	-3.21%
1 month	-9.93%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Stifel Adjusts Price Target on DexCom to $132 From $145	Jul. 12	MT
UPC Issues Two First Instance Decisions On Infringement	Jul. 11	AQ
DexCom, Inc. : A Must-Have Tool for Diabetes Care	Jul. 10
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time	Jun. 28	AQ

More news

Quotes 5-day view

Date	Price	Change
24-07-12	41.91	+2.59%
24-07-11	40.85	+0.12%
24-07-10	40.8	-0.49%
24-07-09	41	-4.14%
24-07-08	42.77	+3.99%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 04:34 am EDT

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Morgan Stanley
WKN	MF67PA
ISIN	DE000MF67PA6
Date issued	2018-06-20
Strike	56.34 $
Maturity	Unlimited
Parity	1.23 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	172.3 €
Lowest since issue	8.13 €

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

114.1 USD

Average target price

149.8 USD

Spread / Average Target

+31.33%

Consensus